Cargando…
A multiple therapy hypothesis for treatment of COVID-19 patients
The coronavirus disease 2019 (COVID-19) pandemic, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has killed more than one million people as of October 1, 2020. Consequently, a search is on for a treatment that can bring the pandemic to an end. However, treatment...
Autor principal: | Oscar, Thomas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Eden Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577273/ https://www.ncbi.nlm.nih.gov/pubmed/33129008 http://dx.doi.org/10.1016/j.mehy.2020.110353 |
Ejemplares similares
-
Hypothesis of COVID-19 Therapy with Sildenafil
por: Mario, Limodio, et al.
Publicado: (2020) -
Hypoxemia in COVID-19 patients: An hypothesis
por: Fisher, H.K.
Publicado: (2020) -
Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment
por: Smieszek, Sandra P., et al.
Publicado: (2020) -
COVID-19: the androgen hypothesis
por: John, Jeff, et al.
Publicado: (2020) -
Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19
por: Bai, Xiyuan, et al.
Publicado: (2021)